Trial Search Results
Lymphedema Prophylaxis in Breast Cancer Survivors Who Show Early Evidence of High-risk Status
To compare the effectiveness of usual treatments for lymphedema [massage and elastic compression sleeve, instituted at-risk and before the development of swelling (lymphedema)], compared to the use of a newly-marketed device, the Flexitouch, which electronically simulates the effect of massage upon lymph flow.
Stanford is currently not accepting patients for this trial.
- Device: Flexitouch
- Device: Class 1 compression garment
- Unilateral breast cancer
- Scheduled to undergo breast surgery and axillary lymph node dissection, with or
without breast conserving techniques.
- Referred to the surgeons of the Stanford University Breast Cancer Program
- Capacity to provide informed consent.
- All experimental protocols will be reviewed and approved by the Stanford Institutional
Review Board for the Protection of Human Subjects.
- Other serious systemic illness (renal failure, hepatic dysfunction, congestive heart
failure, neurological or psychological impairment) that would confound the study or
impair the patients' ability to participate.
- Recurrent breast cancer or other forms of pre-existing lymphedema.
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study